We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Head & neck
Digital Poster
Clinical
Is Gemzar-cisplatin induction chemotherapy less effective than triplet induction chemotherapy in locally advanced nasopharyngeal carcinoma?
Nejla Fourati, Tunisia
E25-662
Frequency and Trends of Re-planning During Adjuvant Radiation Therapy in Oral Cavity Cancer Patients with Flap Reconstruction: A Prospective Analysis
Laraib Khan, Pakistan
E25-3693
Radiological Depth of invasion as a surrogate for need of nodal dissection in oral cavity cancers: A retrospective anlaysis.
Pragyat Thakur, India
E25-3703
Comparison between T1-, T2- and T1 StarVibe-weighted MRI and contrast-enhanced CT based delineation of organs at risk in head and neck radiotherapy
Adelina Brezae, Romania
E25-3761
Quality of life and financial toxicity in head and neck cancer patients treated with particle therapy: a prospective study (NCT05947149)
Rossana Ingargiola, Italy
E25-3788
Surgery versus radiotherapy in T2N0 laryngeal cancer: A unicentric retrospective study
Nicolas DENY, France
E25-3929
Outcomes in anaplastic thyroid carcinoma after spatially fractionated radiotherapy
Elizabeth McKone, USA
E25-3988
Evaluation of a deep-learning based auto-segmentation tool for organs at risk in extensively preoperated head and neck cancer patients
Norina Predescu, Romania
E25-4004
Management of head and neck squamous cell carcinoma with N3 nodal disease
Lei Wang, United Kingdom
E25-769
Prognostic factors and outcomes in oral cavity cancer patients:
Jesus Romero Fernandez, Spain
E25-4020
treatment outcomes of intra-arterial chemoradiotherapy for locally advanced tongue cancer
Yutaka Toyomasu, Japan
E25-4047
Outcome Prediction Before Definitive Chemoradiation in Older Adults With Head-and-Neck Cancer Using Artificial Neural Networks
Sebastian Norbert Marschner, Germany
E25-4086
The value of re-resection to achieve R0 status in HNSCC patients undergoing adjuvant chemoradiation – preliminary results of a monocenter study
Erik Haehl, Germany
E25-4106
Impact of sarcopenia on acute toxicity for head and neck cancer patients treated with hadrontherapy: a prospective study (NCT06207708)
Rossana Ingargiola, Italy
E25-4136
Benchmarking Multi-Specialty Interobserver Performance in Radiographic Detection and Staging of Mandibular Osteoradionecrosis Using the ClinRad System
Zeph Kaffey, USA
E25-4195
Outcomes of proton therapy in the treatment of sinonasal cancers: a single-center experience.
Rossana Ingargiola, Italy
E25-4230
Financial toxicity in Romanian head and neck cancer patients – a cross-sectional study
Renata Zahu, Romania
E25-4241
Definitive hypofractionated radiotherapy of head and neck squamous cell carcinoma (HNSCC) in frail and elderly patients
Petra Štefková, Slovakia
E25-805
The bacterial composition of Head and Neck tumours can resolve hypoxia/immune gene expression-based prognosis in patients with mixed patterns
Jacopo Iacovacci, Italy
E25-4247
incidence of nodal involvement of IX level in Head & Neck cancer: a multicenter retrospective analysis.
Fabrizio Sanna, Italy
E25-4261
Psychological Impact of Radiodermatitis After Radiotherapy for Head and Neck Cancer: A 5-Year Retrospective Study
FATIMA ZAHRA CHRAA, Morocco
E25-4331
Prognostic capacity of pretreatment hematological parameters in patients with Head and neck cancer treated with chemo-bio Radiotherapy
Laura Montezuma , Spain
E25-4340
Investigation of a novel methodology to select patients for PTV margin reduction via daily adaptive radiotherapy for head and neck cancer
Andrew Mcpartlin, Canada
E25-4365
Impact of active smoking on early survival and acute severe toxicities of patients treated with radiotherapy for head and neck cancer.
Louis Munschi, France
E25-4367
GLIM-based Malnutrition Prevalence in Head and Neck Cancer Patients Undergoing Treatment: A Prospective Study
Mariangela Massaccesi, Italy
E25-4396
Efficacy of an epigallocatechin gallate mouthwash in the prevention of radiation-induced mucositis in locally advanced head and neck cancer
BIANCA SANTO, Italy
E25-4403
influence the interval time between surgery and start of adjuvant radiotherapy for head and neck cancer prognosis
Scarlet Marie Crespo Perez, Spain
E25-4419
Mucosa sparing strategy in Head and neck cancers treated with hypofractionated carbon-ion therapy
Ankita Nachankar, Austria
E25-870
Long-term Outcomes of Salivary Gland Cancer: A Five-Year Analysis of Survival and Disease Control from a Single Center
Carmen Hernandez-Carrillo Martínez-Almeida, Spain
E25-4421
Squamous cell carcinoma of nasal vestibule: the prognostic role of the four staging system classifications
Stefano Durante, Italy
E25-4493
Clinical outcomes and QOL in 39 patients with head and neck mucosal melanoma after hypofractionated spot scanning proton therapy: retrospective study
Koichiro Nakajima, Japan
E25-903
A systematic review and proportional meta-analysis of image-based pattern of loco-regional failure outcomes in head and neck squamous cell carcinoma
Morten Horsholt Kristensen, Denmark
E25-923
Acute kidney injury following radical chemo-radiotherapy for head and neck cancer: a review of practice at a tertiary oncology centre
Leah Brooks, United Kingdom
E25-937
Pretreatment APOE levels and survival in nasopharyngeal carcinoma: A retrospective analysis.
Xianming He, China
E25-986
Low-dose Fractionated Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Controlled Trial?NCT05292027?
Mei Feng, China
E25-232
Base of tongue volume and dose as predictors of late dysphagia in oral cavity cancer patients treated with IMRT: a retrospective analysis.
Joseph Azria, France
E25-1011
Stereotactic radiotherapy for cT1-2 glottic larynx cancer on MR-Linac: preliminary results of a treatment planning study
Sabine Linden, The Netherlands
E25-1082
Dose-Response Characteristics and Predictive Study of Radiation Dermatitis in the Neck Region during Nasopharyngeal Cancer Radiotherapy
Haiyan Peng, China
E25-1106
Machine Learning Prediction of Secondary Recurrence in Head and Neck Cancer after Reirradiation Using a Weighted Average Model on Pre-reRT PET Imaging
Arnaud Beddok, France
E25-1238
Evaluating Quad Shot Radiotherapy for Locally Advanced Head and Neck Cancer: A Multicenter Analysis of Factors Influencing Survival
Jordan Stanton, United Kingdom
E25-1272
Conventional Fractionation vs. Stereotactic Body Radiotherapy: A Comparative Approach in Postoperative Management of Head and Neck Sarcomas
Alper Kahvecioglu, Turkey
E25-1308
Tubarial gland sparing for oropharyngeal cancer: Feasibility with Intensity Modulated Proton Therapy & Intensity Modulated Radiation Therapy
Omer Gal, USA
E25-245
Navigating neurocognition; feasibility of online neurocognitive assessment in survivors of oropharyngeal cancer
Zsuzsanna Iyizoba-Ebozue, United Kingdom
E25-1373
Exploring Gender-Specific Nutritional Disparities in Head and Neck Cancer Patients Treated with (Chemo)Radiotherapy
Anastassia Löser, Germany
E25-1383
Selection strategy for adaptive radiotherapy in patients with nasopharyngeal cancer: a single institution experience
Sandra Nuyts, Belgium
E25-1485
Implementation of Spatially Fractionated Radiotherapy (SFRT) in Palliative Treatment of Advanced Head and Neck Cancers
Tomasz Winiecki, Poland
E25-1515
Comparative Dosimetric Analysis of Radiotherapy Techniques for Early Vocal Cord Carcinoma: A Single-Center Experience
Frandeina Pinto Guevara, Spain
E25-1588
Geriatric head and neck squamous cell carcinomas (GHNC) treated with modulated radiotherapy (MRT): Preliminary single Institution outcome.
Jay Prakash Sahu, India
E25-1619
Long-term treatment outcomes of patients with oral tongue squamous cell carcinoma in a multidisciplinary tertiary care setting.
Nwaf Alkhanein , Saudi Arabia
E25-1626
Fear of cancer recurrence in adults with HPV-positive oropharyngeal cancer after (chemo)radiation – A bicentric cross-sectional observational study
Alexander Rühle, Germany
E25-1633
Dosimetric trismus predictors in HNC: interim analysis of a prospective international study
Orges Spahiu, Albania
E25-1636
Cephalometric findings predict trismus in HNC patients: interim analysis of a prospective international study
Orges Spahiu, Albania
E25-1643
Hyperfractionated chemoradiotherapy in locally-advanced unresectable head and neck squamous cell carcinoma: a prospective study
Reza Ghalehtaki, Iran Islamic Republic of
E25-1790
Photobiomodulation in head and neck cancer patients undergoing chemoradiotherapy: role in toxicities prevention, update data
Margherita Rotondi, Italy
E25-1866
A single institution study on patterns of relapse and survival outcomes in head and neck salivary gland carcinomas treated with surgery and IMRT
Justin Kar Wai Ng, China, Hong Kong Special Administrative Region
E25-1879
Efficacy of immunotherapy in Epstein-Barr Virus-Negative Recurrent/Metastatic Nasopharyngeal Carcinoma: A Study from Non-High-Incidence Areas
Lei Wang, China
E25-1973
Safe variation from the “5+5” expansion rule for the delineation of primary tumor clinical target volume (CTV-P) in oropharyngeal cancer
Carlotta Becherini, Italy
E25-1991
A prospective study about oral nutrition supplement in local advanced nasopharyngeal carcinoma patients: an update of long-term survival
Yuan-yuan Chen, China
E25-2011
The utility of F-18 FDG PET-CT imaging in the work-up and management of salivary gland malignancies
Yashna Nadkarni, United Kingdom
E25-2045
Olfactory function in nasopharyngeal carcinoma patients after radiotherapy: a preliminary report of a prospective cohort study.
Kansiree Benjangkhaprasert, Thailand
E25-2100
Value of diffusion-weighted MRI for persistent skull base invasion of nasopharyngeal cancer after radiotherapy
Sergi Benavente, Spain
E25-2133
The effect of evolving clinical practice in head and neck radiotherapy: auto-planning and new CTV guidelines
Eva Onjukka, Sweden
E25-2285
The impact of haemoglobin and package time on head and neck squamous cell cancer outcomes after radical surgery and adjuvant radiotherapy
Lei Wang, United Kingdom
E25-2310
Characterization of distant metastases in salivary gland cancer patients undergoing upfront surgery followed by postoperative radiation therapy
Dong Soo Lee, Korea Republic of
E25-2311
Effects of scheduled replanning during dose painting on organs at risk for head and neck squamous cell carcinoma
Anneliz de Leeuw, The Netherlands
E25-2329
PATTERNS OF FAILURE IN PORT IN ADENOID CYSTIC CARCINOMA: 13 YEARS EXPERIENCE
Pablo Araguas Mora, Spain
E25-2331
Evaluation of Submandibular Gland Function Using Quantitative Pertechnetate Scintigraphy in Submandibular-Sparing Radiation for Head and Neck Cancers
Prasoon Garg, India
E25-454
Selective mucosal and nodal irradiation in patients of head and neck carcinoma of unknown primary (HNCUP): Emergence of primary, outcome and toxicity.
Monali Swain, India
E25-2453
Bayesian analysis of dose to the medulla oblongata and dysphagia One-Year after head and neck radiotherapy
Golnoosh Motamedi-Ghahfarokhi, United Kingdom
E25-2482
The morphological and dosimetric changes of target volumes and organs at risk during radiotherapy for nasopharyngeal carcinoma
Guanqun Zhou, China
E25-2526
Acute Toxicity Comparison Between IMPT and VMAT for Nasopharyngeal Cancer: A Propensity Score-Matched Analysis
Kiattisa Sommat, Singapore
E25-2646
Recurrence Patterns After Definitive Radiotherapy for SCC Locally Advanced Pharyngeal and Laryngeal: Real-World Insights in the Modern Era!
Linda Agolli, Germany
E25-2665
Curative proton reirradiation (re-PT) in recurrent head and neck cancers (HNC): outcomes and toxicities
Seedarat Suwichanarakul, Thailand
E25-457
Radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on MR-linac: preliminary outcomes and comparison with helical tomotherapy
Andrea Guerini, Italy
E25-2747
Cross-Sectional Sternocleidomastoid Muscle Area in MRI as a Marker for Sarcopenia and Survival Outcomes in Nasopharyngeal Cancer Patients
JENG-YOU WU, Taiwan, Province of China
E25-2749
Feasibility of reduced margin daily online adaptive radiotherapy(DART) in head and neck cancer-interim technical analysis of ongoing prospective study
HARJOT KAUR BAJWA, India
E25-2770
Fighting xerostomia in head and neck patients treated with radiotherapy: the challenging strategy of the parotid gland stem cell sparing.
Daniela Alterio, Italy
E25-2790
Do pretreatment CT and PET radiomics predict individual lymph node failure after (chemo)radiotherapy in head and neck cancer patients?
Nanna Sijtsema, The Netherlands
E25-2791
Prognostication with lymphocyte counts and their kinetics during chemoradiotherapy for HPV-positive oropharyngeal carcinoma
Andrew Mcpartlin, Canada
E25-2792
Survival outcomes of HPV-negative Head and Neck cancer patients treated by definitive radiotherapy or radiochemotherapy: data from three centers.
Marek Slavik, Czech Republic
E25-2907
Contrastive Learning Guided by Clinical Risk Scores Enhances WSI-Based Progression-Free Survival Prediction in Head and Neck Cancer
Shirin A. Enger, Canada
E25-2983
EORTC 2014-HNCG PROLoNg: Pembrolizumab and Radiotherapy for OLigometastatic squamous cell carcinoma of the head and Neck, randomized phase III trial
Panagiotis Balermpas, Switzerland
E25-3002
Identifying modifiable patient and treatment characteristics in long-term PEG-dependent head and neck cancer patients
Saeed Salman, Canada
E25-3018
Adjuvant radiotherapy for pleomorphic dermal sarcoma of the head and neck
Matthew Fahy, Ireland
E25-3069
Stereotactic boost radiotherapy to head and neck cancer patients: single institution experience
Vitali Moiseenko, USA
E25-3120
Outcomes of Palliative Hypofractionated Radiotherapy with 50 Gy in 20 fractions with or without a treatment Break in Head and Neck Cancer Patients
AARTHI IYER, Canada
E25-3172
Regional recurrence rates in clinically node negative sinonasal cancers without elective neck treatment
osagie igiebor, USA
E25-3178
Automated imaging-based tumor burden predicts pre-treatment circulating tumor DNA in HPV-associated oropharynx cancers
Mina Bakhtiar, USA
E25-3181
Influence of testosterone supplementation on HPV-positive oropharyngeal squamous cell carcinoma outcomes after radiotherapy
Andres Frias, USA
E25-3218
Quality of life and return to work after radiotherapy in young adults with head-and-neck cancer – A bicentric cross-sectional observational study
Alexander Rühle, Germany
E25-588
Research on the application of Raman spectroscopy in predicting the efficacy of nasopharyngeal carcinoma treatment and assessing adverse reactions
peng zhang, China
E25-3234
Integrating Dosimetric and Tooth Avulsion Status for Personalized Risk Prediction of Mandibular Osteoradionecrosis in Head and Neck Cancer
Ahmed Allam Mohamed, Germany
E25-3402
Zinc Gluconate Oral Spray for Preventing Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy: Preliminary Results from a RCT.
Mariangela Massaccesi, Italy
E25-3491
ITHACA-ORION: Tools for Head and Neck Cancer – Early Post-Operative NI-RADS to Predict Recurrence in High-Risk Oral Cancer.
Mariangela Massaccesi, Italy
E25-3522
prospective clinical validation of a fully automated decision making system for adaptive radiotherapy in nasopharyngeal carcinoma
Guanqun Zhou, China
E25-3532
Efficacy of administering pentoxifylline, tocopherol, with or without clodronate, to irradiated head and neck cancer patients with osteoradionecrosis
Dustin Jan Cruz, Philippines
E25-3583
Tumor asphericity a novel FDG-PET parameter for risk stratification head and neck squamous cell carcinoma
Patrick Hausmann, Germany
E25-3599
Early Results Of RadiomicART Trial: A Prospective Monocenter Study Of Multi-Imaging Adaptive Radiotherapy For Locally Advanced Head-Neck Cancer
Mariya Boyanova Ilieva, Italy
E25-3691